Hoeilaart, Belgium

Serge V M Muyldermans


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Serge V M Muyldermans in Antibody Production**

Introduction

Serge V M Muyldermans is an accomplished inventor based in Hoeilaart, Belgium, known for his pioneering work in the field of immunology. With a focus on the production of antibodies derived from heavy chain immunoglobulins of camelidae, he has made significant advancements that have implications in various biotechnological applications.

Latest Patents

Serge holds a patent for a novel process aimed at the production of antibodies and functionalized fragments derived from heavy chain immunoglobulins. This innovative method utilizes transformed lower eukaryotic hosts, such as molds and yeasts, carrying DNA sequences that encode these antibodies. Notably, these antibodies are unique as they are devoid of light chains, allowing for advanced applications in therapeutic and diagnostic fields. His patent also discusses the possibility of grafting complementary determining regions (CDRs) to enhance antibody capabilities and includes the production of catalytic antibodies raised against transition state molecules.

Career Highlights

Serge V M Muyldermans currently works at Bac IP B.V., where he continues to contribute to the development of biotechnological solutions that utilize camelidae-derived antibodies. His research has notably enhanced our understanding of immunoglobulin functions and their applications in health-related fields.

Collaborations

Throughout his career, Muyldermans has collaborated with talented colleagues such as Raymond Hamers and Cecile Hamers-Casterman. Their collective efforts have enriched the research environment, driving innovations in antibody production and expanding the scope of their practical applications.

Conclusion

In summary, Serge V M Muyldermans stands out as a key inventor in the biotechnology sector, particularly in the domain of antibody development and functionalization. His contributions not only advance scientific knowledge but also offer potential therapeutic solutions that could significantly impact the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…